Global Autotransfusion Systems Market, By Type (Products, Accessories, Autotransfusion Types, Postoperative Autotransfusion Systems, Dual-Mode Autotransfusion Systems), Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, Others), End-Use (Hospitals, ASCs, Others) – Industry Trends and Forecast to 2030.
Autotransfusion Systems Market Analysis and Size
According to the American Heart Association, over 80 million people worldwide are victims of heart disease caused by an unhealthy diet, increased stress, and a lifestyle change resulting in a haemorrhage in 2019. According to the World Health Organization, most thalassemia infants are born in low-income countries where blood transfusion is difficult or available to only a small percentage of the population.
Data Bridge Market Research analyses that the autotransfusion systems market which is USD 492.2 million in 2022, is expected to reach USD 761.12 million by 2030, at a CAGR of 5.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Autotransfusion Systems Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Products, Accessories, Autotransfusion Types, Postoperative Autotransfusion Systems, Dual-Mode Autotransfusion Systems), Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation, Trauma Procedures, Others), End-Use (Hospitals, ASCs, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
BD (U.S.), Beijing Zhongke Zhengfang Technology Co., LTD (China), Braile Biomédica (Brazil), Fresenius SE & Co. KGaA (Germany), Gen World Medical Devices (India), Haemonetics Corporation (U.S.), LivaNova PLC (U.K.), Medtronic (Ireland), SARSTEDT AG & Co. KG (Germany), Teleflex Incorporated (U.S.), Zimmer Biomet (U.S.), Advancis Surgical (U.K.) and B. Braun SE (Germany)
|
|
Market Opportunities
|
|
Market Definition
Autotransfusion systems are a medical device that collects and processes the patient's blood during a specific surgical procedure, thereby reducing the need for any blood transfusion from an external donor. This device's sophisticated operational design allows it to supply the necessary autologous blood during various device applications.
Autotransfusion Systems Market Dynamics
Drivers
- Increase in the number of organ transplant procedures
Over the years, there has been an increase in the number of organ transplant procedures. According to the Global Observatory on Donation and Transplantation (GODT), the number of organs transplanted in 2017 was 139,024, an increase of 7.3% over 2015. In 2017, there were 16 transplants performed per hour. In 2017, 90,306 kidney transplants and 32,348 liver transplants were performed. This rising demand for organ transplants is driving demand for autologous blood transfusion for patients' blood management during the organ transplantation procedure.
Preoperative autologous transfusion involves collecting and storing patients' blood for a period of time. Blood collection in advance is normally impossible because there is no set a date for liver transplants, except for cases involving living donors. As a result, intraoperative blood salvage autotransfusion (IBSA) is used as an autologous transfusion strategy. IBSA involves recovering blood lost during the procedure and reintroducing it into the patient's body via infusion. This eliminates the need for an allogeneic blood transfusion, which could affect recipient survival and have an immunosuppressive effect. Allogeneic transfusion raises the risk of viral infection transmission and transfusion errors among patients. This, in turn, is contributing to the demand for autotransfusion systems in organ transplant procedures to manage blood loss and increase safety and effectiveness during the procedure.
Opportunities
Restraints/Challenges
- High cost of systems
Concerns about the high cost of these systems, increased public awareness about the risks associated with this system, and various initiatives and programmes organized by governments to promote blood donation globally are the major factors acting as restraints, and will further challenge the growth of the autotransfusion systems market during the forecast period.
One of the factors impeding the growth of the autotransfusion systems market is the high cost of autotransfusion. The most common type of heart surgery costs between $25,000 and $250,000, depending on the type of surgery, surgeons involved, and the facility where the surgery is performed.
This autotransfusion systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the autotransfusion systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2020, ProCell Surgical Inc. launched its first medical device, designed to automate surgical sponge-blood recovery's outdated and manual activity for intraoperative autotransfusion.
Global Autotransfusion Systems Market Scope
The autotransfusion systems market is segmented on the basis of type, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Products
- Accessories
- Autotransfusion Types
- Postoperative Autotransfusion Systems
- Dual-Mode Autotransfusion Systems
Application
- Cardiac Surgeries
- Orthopedic Surgeries
- Organ Transplantation
- Trauma Procedures
- Others
End-Use
- Hospitals
- ASCs
- Others
Autotransfusion Systems Market Regional Analysis/Insights
The autotransfusion systems market is analyzed and market size insights and trends are provided by country, type, application and end-use as referenced above.
The countries covered in the autotransfusion systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the autotransfusion systems market due to a scarcity of blood donors and donated blood volume and the high volume of transplantation-based procedures in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The autotransfusion systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for autotransfusion systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the autotransfusion systems market. The data is available for historic period 2011-2021.
Competitive Landscape and Autotransfusion Systems Market Share Analysis
The autotransfusion systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to autotransfusion systems market.
Some of the major players operating in the autotransfusion systems market are:
- BD (U.S.)
- Beijing Zhongke Zhengfang Technology Co., LTD (China)
- Braile Biomédica (Brazil)
- Fresenius SE & Co. KGaA (Germany)
- Gen World Medical Devices (India)
- Haemonetics Corporation (U.S.)
- LivaNova PLC (U.K.)
- Medtronic (Ireland)
- SARSTEDT AG & Co. KG (Germany)
- Teleflex Incorporated (U.S.)
- Zimmer Biomet (U.S.)
- Advancis Surgical (U.K.)
- B. Braun SE (Germany)
SKU-